| 1 |
34896479 | ZFP36 protects against oxygen-glucose deprivation/reoxygenation-induced mitochondrial fragmentation and neuronal apoptosis through inhibiting NOX4-DRP1 pathway. | 2022 Feb |
1 |
| 2 |
35525391 | Clinical implications of tristetraprolin (TTP) modulation in the treatment of inflammatory diseases. | 2022 May 5 |
2 |
| 3 |
34090459 | The functional characterization of phosphorylation of tristetraprolin at C-terminal NOT1-binding domain. | 2021 Jun 5 |
2 |
| 4 |
31036567 | Importance of the Conserved Carboxyl-Terminal CNOT1 Binding Domain to Tristetraprolin Activity In Vivo. | 2019 Jul 1 |
1 |
| 5 |
18256032 | Genome-wide analysis identifies interleukin-10 mRNA as target of tristetraprolin. | 2008 Apr 25 |
3 |
| 6 |
15226444 | Chorioallantoic fusion defects and embryonic lethality resulting from disruption of Zfp36L1, a gene encoding a CCCH tandem zinc finger protein of the Tristetraprolin family. | 2004 Jul |
1 |
| 7 |
10706852 | Evidence that tristetraprolin is a physiological regulator of granulocyte-macrophage colony-stimulating factor messenger RNA deadenylation and stability. | 2000 Mar 15 |
1 |
| 8 |
10330172 | Evidence that tristetraprolin binds to AU-rich elements and promotes the deadenylation and destabilization of tumor necrosis factor alpha mRNA. | 1999 Jun |
1 |